| Net Cash Provided by (Used in) Operating Activities |
-3,315,172 |
USD |
-51.1% |
Q2 2025 |
Q1 2026 |
| Net Cash Provided by (Used in) Financing Activities |
6,496,216 |
USD |
|
Q2 2025 |
Q1 2026 |
| Common Stock, Shares Authorized |
200,000,000 |
shares |
0% |
Q2 2025 |
Q1 2026 |
| Common Stock, Shares, Issued |
14,026,030 |
shares |
+30.7% |
Q2 2025 |
Q1 2026 |
| Common Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q2 2025 |
Q1 2026 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
3,181,044 |
USD |
|
Q2 2025 |
Q1 2026 |
| Deferred Tax Assets, Valuation Allowance |
14,619,000 |
USD |
+22.3% |
Q1 2025 |
FY 2025 |
| Deferred Tax Assets, Gross |
16,349,000 |
USD |
+19.4% |
Q1 2025 |
FY 2025 |
| Operating Lease, Liability |
97,631 |
USD |
+73.1% |
Q2 2025 |
Q1 2026 |
| Depreciation |
8,436 |
USD |
+3.8% |
Q2 2025 |
Q1 2026 |
| Lessee, Operating Lease, Liability, to be Paid |
106,548 |
USD |
+81.1% |
Q2 2025 |
Q1 2026 |
| Property, Plant and Equipment, Gross |
605,455 |
USD |
+1% |
Q2 2025 |
Q1 2026 |
| Operating Lease, Liability, Current |
53,438 |
USD |
+0.56% |
Q2 2025 |
Q1 2026 |
| Lessee, Operating Lease, Liability, to be Paid, Year Two |
14,400 |
USD |
|
Q2 2025 |
Q1 2026 |
| Lessee, Operating Lease, Liability, to be Paid, Year One |
43,200 |
USD |
+2.3% |
Q2 2025 |
Q1 2026 |
| Operating Lease, Weighted Average Discount Rate, Percent |
0.1 |
pure |
+25% |
Q2 2025 |
Q1 2026 |
| Lessee, Operating Lease, Liability, Undiscounted Excess Amount |
8,917 |
USD |
+2.6% |
Q2 2025 |
Q1 2026 |
| Deferred Tax Assets, Operating Loss Carryforwards |
14,586,000 |
USD |
+18.4% |
Q1 2025 |
FY 2025 |
| Preferred Stock, Shares Issued |
0 |
shares |
|
Q2 2025 |
Q1 2026 |
| Preferred Stock, Shares Authorized |
50,000,000 |
shares |
0% |
Q2 2025 |
Q1 2026 |
| Operating Lease, Payments |
15,423 |
USD |
+1.1% |
Q2 2025 |
Q1 2026 |
| Additional Paid in Capital |
121,998,142 |
USD |
+35.1% |
Q2 2025 |
Q1 2026 |
| Preferred Stock, Shares Outstanding |
0 |
shares |
|
Q2 2025 |
Q1 2026 |
| Deferred Tax Assets, Net of Valuation Allowance |
1,730,000 |
USD |
-0.52% |
Q1 2025 |
FY 2025 |
| Share-based Payment Arrangement, Expense |
55,267 |
USD |
+4.9% |
Q2 2025 |
Q1 2026 |
| Preferred Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q2 2025 |
Q1 2026 |